Company intelligence / Profile preview

Fionet Rapid Response Group

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

The Fionet Platform is an end-to-end rapid testing and tracking solution for infectious diseases, with demonstrated high-throughput use in real-world deployments, such as COVID-19 testing at Toronto Pearson Airport (reducing wait times from 4 hours to under 1) and national malaria containment pilots in Rwanda, and has supported over a million tests across more than a dozen countries.

Therapeutic areas: Infectious Diseases
Modalities: DeviceDiagnostic platformSoftware
Industry: Molecular Diagnostics

Partnerships

LifeLabsMinistry of Health (Rwanda)Abbott Laboratories (COVID-19 RDT supplier)Roche Diagnostics (COVID-19 RDT supplier)

Beyond the preview

Go deeper on Fionet Rapid Response Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fionet Rapid Response Group.

Explore the full profile